Sustainability & Impact

Statement on Principal Adverse Impacts SFDR Article 9 – Summary of Sustainability Disclosures SFDR Article 8 – Summary of Sustainability Disclosures Report on Principle Adverse Impacts (2024) SFDR Article 9 – MED Platform II – Periodic Disclosure (2024) SFDR Article 8 – MED Platform I – Periodic Disclosure (2024) SFDR Article 8 – MPI – COI – CARSO S.L.P – Periodic Disclosure (2024) SFDR Article 8 – MPI – COI – NAMSA S.L.P – Periodic Disclosure (2024) SFDR Article 8 – MPI – COI – NMI S.L.P – Periodic Disclosure (2024) SFDR Article 8 – MPI – COI – Prollenium S.L.P – Periodic Disclosure (2024) SFDR Article 8 – MPI – COI – SUAN S.L.P – Periodic Disclosure (2024) SFDR Article 8+ – MED III – Periodic Disclosure (2024) SFDR Article 8 – MED Access – Periodic Disclosure (2024) SFDR Article 8 – MED Bio – Periodic Disclosure (2024) SFDR Article 8 – MED II – Periodic Disclosure (2024) SFDR Article 8 – MED I – Periodic Disclosure (2024) SFDR Article 8+ – MED Rise – Periodic Disclosure (2024)